A Novel Therapeutic Strategy for Pancreatic Cancer: Targeting Cell Surface Glycan Using rBC2LC-N Lectin-Drug Conjugate (LDC)
Molecular cancer therapeutics, 2018-01, Vol.17 (1), p.183-195 [Peer Reviewed Journal]2017 American Association for Cancer Research. ;Copyright American Association for Cancer Research Inc Jan 2018 ;ISSN: 1535-7163 ;EISSN: 1538-8514 ;DOI: 10.1158/1535-7163.mct-17-0232 ;PMID: 28939555
Full text available